Real-world Orkambi Cork (ROCK) study - a prospective 12 months analysis addressing the impact of CFTR modulation in patients with cystic fibrosis homozygous for F508del CFTR variant
dc.check.info | Controlled Access | |
dc.contributor.advisor | Plant, Barry | |
dc.contributor.advisor | Eustace, Joe | |
dc.contributor.author | Arooj, Parniya | |
dc.date.accessioned | 2025-02-18T14:40:09Z | |
dc.date.available | 2025-02-18T14:40:09Z | |
dc.date.issued | 2024 | |
dc.date.submitted | 2024 | |
dc.description | Controlled Access | |
dc.description.abstract | Cystic fibrosis (CF) stands as one of modern medicine's success stories, with significant and sustained improvements in survival rates, transforming it from a childhood fatal condition to one of adult survival. Historically, CF management has centered on addressing the consequences of CFTR dysfunction. The introduction of Lumacaftor-Ivacaftor marks a pivotal shift, allowing researchers to assess the impact of CFTR function restoration on both pulmonary disease and extrapulmonary manifestations. Globally, approximately 82% of individuals with CF are homozygous for the F508del mutation, whereas this prevalence is 53% at the Cork CF centre. This study examines the effects of CFTR modulation on clinical outcomes, patient-reported measures, systemic and airway inflammation, and lung microbiota composition. | en |
dc.description.status | Not peer reviewed | en |
dc.description.version | Accepted Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.citation | Arooj, P. 2024. Real-world Orkambi Cork (ROCK) study - a prospective 12 months analysis addressing the impact of CFTR modulation in patients with cystic fibrosis homozygous for F508del CFTR variant. MD Thesis, University College Cork. | |
dc.identifier.endpage | 180 | |
dc.identifier.uri | https://hdl.handle.net/10468/17064 | |
dc.language.iso | en | en |
dc.publisher | University College Cork | en |
dc.rights | © 2024, Parniya Arooj. | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | CFTR modulation | |
dc.subject | Cystic fibrosis | |
dc.subject | Lumacaftor-Ivacaftor | |
dc.title | Real-world Orkambi Cork (ROCK) study - a prospective 12 months analysis addressing the impact of CFTR modulation in patients with cystic fibrosis homozygous for F508del CFTR variant | |
dc.type | Doctoral thesis | |
dc.type.qualificationlevel | Doctoral | |
dc.type.qualificationname | MD - Doctor of Medicine |
Files
Original bundle
1 - 2 of 2
Loading...
- Name:
- AroojPA_MD2024.pdf
- Size:
- 10.77 MB
- Format:
- Adobe Portable Document Format
- Description:
- Full Text E-thesis
Loading...
- Name:
- AroojPA_MD2024_Submission for examination form.pdf
- Size:
- 242.12 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 5.2 KB
- Format:
- Item-specific license agreed upon to submission
- Description: